DD-20207

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameDD-20207
Drug Alias NameDD-20199DD-202021DD-20197DD-202012DD-20207 +[7] 
ClassificationSmall molecules
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsNeuroprotectants
TargetsGlutamate [NMDA] receptor
Therapy Area/IndicationsNeuralgiaAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiverdrugs
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiverdrugs
Active IndicationsN/A
Inactive IndicationsNeuralgiaAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A